Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
ID: 356401Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $500K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356401

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-26-002.html
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for the Urology Centers Program Interactions Core (U24), aimed at enhancing collaboration and coordination within the urological research community. This initiative seeks to promote innovative, interdisciplinary research on benign urological diseases while supporting the training of emerging researchers through productive partnerships among the U54 and P20 Centers, career development programs, and external investigators. The program emphasizes inclusion and equal opportunity among applicants, with funding available up to $500,000, and applications are due by November 21, 2024, with potential funding commencing shortly thereafter. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-26-002.html.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DK-26-002-Full-Announcement.html
    RFA-DK-26-002.html
    The National Institutes of Health (NIH) has announced a funding opportunity for the Urology Centers Program Interactions Core (U24), aiming to enhance coordination and collaboration within urological research communities. This initiative is designed to foster innovative, interdisciplinary research on benign urological diseases and support the training of emerging researchers. The funding of up to $1 million per year over a maximum of five years will support collaborative activities, including outreach events and educational programs. The application deadlines are set for October 21, 2024, with potential funding beginning in November 2024. Critical to achieving these goals is promoting partnerships between the U54 and P20 Centers, career development programs, and external investigators, thereby expanding the community of urology researchers and strengthening scientific advancements. The program encourages inclusion and equal opportunity among applicants, aiming to bridge knowledge gaps and enhance understanding of urological diseases through diverse interdisciplinary cooperation. Overall, this funding opportunity underlines the NIH's commitment to advancing urological research and training through substantial federal involvement and a collaborative approach among various stakeholders.
    Similar Opportunities
    Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Polycystic Kidney Disease (PKD) Core Centers through a Notice of Funding Opportunity (NOFO) aimed at enhancing national research efforts in PKD. The initiative seeks to establish four Core Centers that will collaborate within the PKD Research Resource Consortium, focusing on developing and sharing essential research tools and resources while promoting scientific diversity and engagement among a wide range of investigators. Approximately $3.44 million in funding is anticipated for FY 2025, with applications due by November 15, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is soliciting applications for the Central Coordinating Site (CCS) for the Polycystic Kidney Disease (PKD) Research Core Centers through Funding Opportunity Number RFA-DK-25-015. The CCS will collaborate with four PKD Research Core Centers to enhance understanding of PKD and promote resource sharing, providing essential administrative support, managing data sharing, and administering pilot project funding. This initiative is crucial for fostering a diverse and collaborative research environment to address the challenges of PKD effectively. The funding opportunity anticipates approximately $1.1 million for one award in FY 2025, with annual budgets around $350,000. Interested applicants must submit their proposals via Grants.gov by November 14, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Institutional Network Award (U2C) to enhance training in kidney, urologic, and hematologic research. This funding opportunity aims to foster a collaborative environment by inviting institutions to submit a unified application that supports a cohort of trainees and early-career investigators, with a strong emphasis on partnerships among institutions within metropolitan areas. The initiative is crucial for reshaping research training and promoting scientific collaboration, ensuring that the next generation of researchers is equipped to address complex biomedical challenges. Applications will be accepted starting October 16, 2023, with a submission deadline of September 27, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Stimulating Urology Interdisciplinary Team Opportunity Research (SUITOR) grant, aimed at promoting innovative interdisciplinary research in benign urologic conditions, specifically focusing on neurourology. This initiative encourages investigator-initiated R01 research projects that address significant knowledge gaps in the field, fostering collaboration among diverse scientific disciplines to enhance understanding of the neural and behavioral mechanisms underlying these conditions. The program has an annual budget of $1,125,000, with approximately three grants awarded each year for a maximum project period of five years. Interested applicants must comply with NIH policies and submit their proposals by May 7, 2025, with further details available at the provided NIH link or by contacting the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)." This initiative aims to support the development of innovative tools and technologies that address significant challenges in kidney, urologic, and hematologic research, encouraging high-risk, exploratory projects that differ from traditional R01 grants. The funding, with a maximum budget of $275,000 over two years, is open to a diverse range of eligible applicants, including various educational institutions and community organizations, with applications due by January 7, 2025. For further details, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-23-119.html.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity for high-risk multi-center clinical study implementation planning via Cooperative Agreements (U34). This initiative aims to support the early peer review of proposed clinical studies, assess study designs, and develop essential documentation, including operational manuals, focusing on diseases relevant to NIDDK's mission. The program emphasizes health equity and inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested applicants can apply for up to $225,000 per year for a maximum of two years, with the application submission period opening on September 9, 2024, and the closing date set for June 10, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting investigator-initiated, high-risk clinical trials that involve multiple clinical centers. Applicants must propose hypothesis-driven studies that focus on diseases relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with an emphasis on enhancing diverse perspectives in research. This funding opportunity is crucial for advancing therapeutic studies that can significantly improve clinical practices and public health outcomes. Interested applicants should note that the application period opens on January 5, 2024, with a closing date of November 5, 2026, and are encouraged to consult with NIDDK staff prior to submission. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Research Resource for Human Organs and Tissues" through a cooperative agreement mechanism (U42), aimed at supporting a program that provides and facilitates the availability of human tissues and organs for biomedical research. The initiative seeks to enhance the procurement, preservation, and distribution of diverse biospecimens, both normal and diseased, to aid researchers in understanding various diseases and addressing public health priorities. Applicants must demonstrate a proven track record in managing a human tissue and organ research resource, with direct costs capped at $720,000 over a potential five-year project period. The application period opens on December 24, 2024, with a submission deadline of September 25, 2025. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Centers for Precision Disease Modeling (U54), aimed at advancing personalized medicine through the integration of animal genomics with human disease research. This initiative invites applications for cooperative agreements that will support collaborative research projects, enhancing preclinical studies by utilizing precision animal models to evaluate disease-causing variants. The program emphasizes the importance of bridging laboratory research with clinical applications to improve patient care, with each application eligible for funding up to $1,250,000 annually over a maximum project period of five years. Proposals are due by December 15, 2024, and interested applicants can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-305.html.
    Biology of Bladder Cancer (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for research into the biology of bladder cancer through the R21 Clinical Trial Optional grant program. This initiative aims to support applications that investigate the molecular mechanisms and biological processes underlying bladder cancer, a significant health issue due to its high incidence and recurrence rates. The program encourages multidisciplinary research that utilizes clinical specimens and explores both normal and cancerous bladder processes, with a funding ceiling of $275,000 available over a two-year period. Interested applicants, including various educational and community organizations, must submit their proposals by September 7, 2025, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov.